MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Utility of deep brain stimulation remote programming for Parkinson’s disease during the COVID-19 outbreak

    CC. Zhang, K.W Zhu, Z.Y Lin, B.M Sun, D.Y Li (Shanghai, China)

    Objective: Deep Brain Stimulation(DBS)tele-programming technique has been available for several years in China, which mainly served as a complementary approach to routine DBS treatment and…
  • MDS Virtual Congress 2020

    Deep brain stimulation revision from VIM to VIM and PSA severe long-standing refractory ET: case series

    S. Aslam, F. Ponce, H. Shill, J. Chan, S. Barbu, M. Lambert, G. Moguel-Cobos (Phoenix, AZ, USA)

    Objective: To describe 5 patients with ET who underwent replacement of VIM DBS with leads targeting both VIM and the posterior subthalamic area (PSA) due…
  • MDS Virtual Congress 2020

    Safety and efficacy of focused ultrasound staged bilateral thalamotomy for Essential tremor

    R. Martinez-Fernandez, J. Pineda-Pardo, J. Mañez-Miró, M. del Álamo, F. Hernandez-Fernandez, R. Rodriguez-Rojas, L. Guida, M. Matarazzo, L. Hermes-Gonzalez, L. Diaz-Fernandez, C. Ammann, L. Vela, J. Obeso (Móstoles, Spain)

    Objective: To report preliminary results on the safety and efficacy of staged bilateral magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy for the treatment of essential tremor…
  • MDS Virtual Congress 2020

    ‘Listen’ to your tremor patient..with a stethoscope!

    J. Siddiqui (Columbia, MO, USA)

    Objective: To report a novel and inexpensive method for evaluating tremor in the clinic and at the bedside. Background: Tremor is the most common involuntary…
  • MDS Virtual Congress 2020

    Feasibility and Acceptability of Lee Silverman Voice Treatment for patients with hereditary ataxia

    A.N. Lowit, A. Egan, M. Hadjivassiliou (Glasgow, United Kingdom)

    Objective: This study aimed to assess the feasibility and acceptability of Lee Silverman Voice Treatment (LSVT) provided via Skype for patients with hereditary ataxia. Background:…
  • MDS Virtual Congress 2020

    New pathogenic mutation in the Niemann-Pick C (NPC) Type 1 gene: Confirmation by diagnostic workup of NPC in a 41-year-old woman with idiopathic late onset cerebellar ataxia (ILOCA)

    G. Crotty, J.Y Chen, D. Brockman, J. Schmahmann (Boston, MA, USA)

    Objective: We present an instructive case of a 41-year-old woman with idiopathic late onset cerebellar ataxia. Background: Identifying the cause of idiopathic late onset cerebellar…
  • MDS Virtual Congress 2020

    Downbeat nystagmus and progressive ataxia mimicking a neurodegenerative disease: a specific phenotype of Chiari malformation

    B. Massuyama, F. Filho, J. Pedroso, O. Barsottini (Sao Paulo, Brazil)

    Objective: Case Report. Background: Chiari malformation type 1 (CM1) is a congenital neurological disease with posterior fossa hypoplasia and the cerebellar tonsils being forced through…
  • MDS Virtual Congress 2020

    Gerstmann-Sträussler-Scheinker disease presenting as a late onset slowly progressive spinocerebellar ataxia: expanding the phenotypic spectrum of genetic prion disease

    C. Stephen, J. Chen, B. Appleby, T. Prior, M. Frosch, J. Schmahmann (Boston, MA, USA)

    Objective: We describe a late-onset presentation of Gerstmann-Sträussler-Scheinker disease (GSS) with a novel mutation in the prion protein (PRNP) gene. We compare this case to…
  • MDS Virtual Congress 2020

    The Impact of Antipsychotic Dose Reduction Within a Medicare Population

    R. Ayyagari, F. Mu, A. Lax, B. Carroll (Boston, MA, USA)

    Objective: To analyze the burden of antipsychotic (AP) dose reduction in Medicare patients with schizophrenia (SZ). Background: Tardive dyskinesia (TD) develops in patients treated with…
  • MDS Virtual Congress 2020

    Ziconotide-Induced Orolingual Dyskinesia: A Case Series

    S. Azher, M. Gupta, B. Dahlben, K. Grajny (Albany, NY, USA)

    Objective: Our aim is to report three cases of orolingual dyskinesia in adults receiving intrathecal ziconotide for chronic pain management. Background: Ziconotide (ZCN), a nonopioid…
  • « Previous Page
  • 1
  • …
  • 89
  • 90
  • 91
  • 92
  • 93
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley